Background: Elderly patients receiving anticancer drugs may have an increased risk to develop treatment-related toxicities compared to their younger peers. However, a potential pharmacokinetic (PK) basis for this increased risk has not consistently been established yet. Therefore, the objective of this study was to systematically review the influence of age on the PK of anticancer agents frequently administered to elderly breast cancer patients. Methods: A literature search was performed using the PubMed electronic database, Summary of Product Characteristics (SmPC) and available drug approval reviews, as published by EMA and FDA. Publications that describe age-related PK profiles of selected anticancer drugs against breast cancer, excluding endocrine compounds, were selected and included. Results: This review presents an overview of the available data that describe the influence of increasing age on the PK of selected anticancer drugs used for the treatment of breast cancer. Conclusions: Selected published data revealed differences in the effect and magnitude of increasing age on the PK of several anticancer drugs. There may be clinically-relevant, age-related PK differences for anthracyclines and platina agents. In the majority of cases, age is not a good surrogate marker for anticancer drug PK, and the physiological state of the individual patient may better be approached by looking at organ function, Charlson Comorbidity Score or geriatric functional assessment.
from #Medicine via ola Kala on Inoreader http://ift.tt/1mpTLFv
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
▼
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
-
▼
Ιανουαρίου
(578)
-
▼
Ιαν 02
(17)
- Utilization of Subcutaneous Methotrexate in Rheuma...
- Healthcare Costs Among Adults with Type 2 Diabetes...
- Work ability and associated factors of Brazilian t...
- Intravesical migration of an intrauterine device
- Poor drug adherence and lack of awareness of hyper...
- Total regression of brain metastases in non-small ...
- Sensors, Vol. 16, Pages 57: Self-Powered WSN for D...
- Materials, Vol. 9, Pages 21: Towards Lead-Free Pie...
- Cancers, Vol. 8, Pages 6: Pharmacokinetics of Sele...
- Materials, Vol. 9, Pages 18: Influence of Blended ...
- Materials, Vol. 9, Pages 19: A Novel Nitinol Spher...
- Materials, Vol. 9, Pages 15: Investigation of High...
- Sensors, Vol. 16, Pages 55: Bio-Inspired Stretchab...
- Sensors, Vol. 16, Pages 48: Geometric and Optic Ch...
- Materials, Vol. 9, Pages 23: Optical and Magneto-O...
- IJMS, Vol. 17, Pages 58: Effect of Chromatin Struc...
- IJERPH, Vol. 13, Pages 88: Cadmium Chloride Induce...
-
▼
Ιαν 02
(17)
Αναζήτηση αυτού του ιστολογίου
Σάββατο 2 Ιανουαρίου 2016
Cancers, Vol. 8, Pages 6: Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.